Saponins
Suppliers
Names
[ CAS No. ]:
8047-15-2
[ Name ]:
Saponins
[Synonym ]:
2,3,4-Tri-O-benzyl-β-D-xylopyranosyl-(1->4)-6-deoxy-2,3-O-isopropylidene-α-L-mannopyranosyl-(1->2)-4-amino-3,6-di-O-benzyl-4-deoxy-1-O-{(3β,16α)-23,28-dioxo-3,16-bis[(triethylsilyl)oxy]o lean-12-en-28-yl}-β-D-galactopyranose
EINECS 232-462-6
β-D-Galactopyranose, O-2,3,4-tris-O-(phenylmethyl)-β-D-xylopyranosyl-(1->4)-O-6-deoxy-2,3-O-(1-methylethylidene)-α-L-mannopyranosyl-(1->2)-4-amino-4-deoxy-1-O-[(3β,16α)-23,28-dioxo-3,
 16-bis[(triethylsilyl)oxy]olean-12-en-28-yl]-3,6-bis-O-(phenylmethyl)-
SAPONINS
MFCD00081981
SAPONINE
Tea Saponin
Sapogenins glycosides
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Melting Point ]:
158℃
[ Molecular Formula ]:
C27H42O3
[ Molecular Weight ]:
1645.293
[ Exact Mass ]:
1643.942505
[ LogP ]:
28.57
[ Index of Refraction ]:
1.583
[ Storage condition ]:
Store at RT.
[ Stability ]:
Stable. Incompatible with strong oxidizing agents.
[ Water Solubility ]:
Do you have solubility information on this product that you would like to share | Soluble in cold water.
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H319-H335
[ Precautionary Statements ]:
P261-P305 + P351 + P338
[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
R36/37
[ Safety Phrases ]:
S26;S37/S39
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
2
[ RTECS ]:
VQ1400000
Articles
PLoS ONE 6 , e22891, (2011)
Trivalent inactivated vaccines (TIV) against influenza are given to 350 million people every year. Most of these are non-adjuvanted vaccines whose immunogenicity and protective efficacy are considered...
J. Neurosci. Methods 247 , 23-31, (2015)
Flow cytometry is an efficient and powerful technique to characterize and quantify numerous cells. However, the strengths of this technique have not been widely harnessed in neurosciences due to the c...
Immunology 125(4) , 469-79, (2008)
Dendritic cells (DCs) play a key role in the type and course of an immune response. The manipulation of human DCs to produce therapeutic agents by transduction with viral vectors is a growing area of ...